Women Health Therapeutics Market Size, Share, Growth Report 2032

Global Women Health Therapeutics Market OVerview

The global Women Health Therapeutics market accrued earnings worth approximately 110(USD Billion) in 2019 and is predicted to gain revenue of about 121 (USD Billion) by 2026, is set to record a CAGR of nearly 8.6% over the period from 2020 to 2026. The report offers assessment and analysis of the Women Health Therapeutics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Synopsis

Women health therapeutics has been gaining significance since last three decades. In 1991, NHLBI (National Heart, Lung, and Blood Institute) of the U.S. NIH (National Institutes of Health) sponsored the Women’s Health Initiative (WHI). As per this initiative, it focusses on various strategies including prevention of heart disorders, colorectal cancer, osteoporosis, and breast cancer in postmenopausal women over the long term. The key WHI study were divided into three parts, namely, clinical study, observational research, and community prevention study. The data collection for the WHI study was completed in 2005 by NIH. Furthermore, WHI contributes majorly towards women’s health & therapeutics through ancillary studies. All these aforementioned factors are anticipated to spearhead the growth of women health therapeutics industry.

Request Free Sample

Market Growth Drivers

Favorable initiatives carried out by NIH that include WHISH (Women’s Health Initiative Strong and Healthy Study), WHISPER (Women’s Health Initiative Sleep Hypoxia Effects on Resilience), and OPACH (Objective Physical Activity and Cardiovascular Health Study) will shape the market growth dimensions over the forecast period. Apart from this, constant surge in occurrence of chronic & lifestyle related diseases in women will embellish women health therapeutics market trends. Furthermore, rise in the funding of healthcare research events along with growing research in the field of oncology & breast cancer will form a strong foundation for women health therapeutics market. With rise in complications pertaining to pregnancy and launching of novel therapeutic drugs for treating the pregnancy related problems, women health therapeutics industry is slated to witness extensive surge within the next couple of years.

Moreover, increment in awareness associated with cancer, infections, menopause, and osteoporosis will proliferate the market size. New drug treatments introduced by giant players of pharma industry will chart a profitable roadmap for women health therapeutics market in the upcoming years. Rise in the infertility rates in women coupled with surge in the gynecological disorders will proliferate the industry size during the years ahead. Favorable government schemes supported by strong healthcare amenities in developed countries as well as emerging nations will kindle the emergence of the market over 2020-2026.

Regional Landscape

North America To Retain Regional Market Dominance Over 2020-2026

The business growth in North America over 2020-2026 can be attributed to large-scale approval of generic medicines by U.S. FDA and occurrence of chronic disorders in women population base. Apart from this, rise in geriatric female population prone to chronic disorders and introduction of new drug therapies to treat such severe ailments will augment market value and add to industry ascension during the assessment period. Moreover, U.S. and Canada are likely to be the key regional growth drivers within the span of next couple of years.

Global Women Health Therapeutics Market: Report Scope:

Key players profiled in the study are Novartis International AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Merck & Co., Inc., Pfizer, Inc., Bayer AG, and Novo Nordisk A/S.

The global Women Health Therapeutics Market is segmented as follows:

 By Type  

• Infection
• Pregnancy
• Oncology

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa